Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.83 is 81% below its 5-year average of 4.26, near the low end of its 5-year range (0.20–30.88).
As of the fiscal period ended Tuesday, June 30, 2026. 50.26% below its 12-month average of 1.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.83.
CURRENT RATIO
0.83
CURRENT RATIO AVG TTM
1.66
CURRENT RATIO AVG 3Y
3.78
CURRENT RATIO AVG 5Y
4.26
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.26%
CURRENT VS 3Y AVG
-78.16%
CURRENT VS 5Y AVG
-80.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-78.00%
vs the sector median at left
Market Cap
$10.39M
Current Ratio
11.22
TTM Avg
10.96
3Y Avg
8.46
5Y Avg
6.93
Market Cap
$10.41M
Current Ratio
2.64
TTM Avg
7.53
3Y Avg
7.44
5Y Avg
5.23
Market Cap
$10.18M
Current Ratio
1.87
TTM Avg
6.94
3Y Avg
8.04
5Y Avg
8.76
Market Cap
$10.10M
Current Ratio
1.57
TTM Avg
1.67
3Y Avg
1.44
5Y Avg
1.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senti Biosciences, Inc. (SNTI) | $10.23M | 0.83 | 1.66 | 3.78 | 4.26 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.39M | 11.22 | 10.96 | 8.46 | 6.93 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | 2.64 | 7.53 | 7.44 | 5.23 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 1.87 | 6.94 | 8.04 | 8.76 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | 1.57 | 1.67 | 1.44 | 1.16 |
| Lifeward Ltd. (LFWD)vs › | $10.10M | 2.33 | 1.70 | 5.47 | 8.37 |
| Polyrizon Ltd. (PLRZ)vs › | $10.80M | 36.37 | 19.59 | 9.84 | 7.09 |
| Pluri Inc. (PLUR)vs › | $10.68M | 0.27 | 0.48 | 3.83 | 4.93 |
| MetaVia Inc. (MTVA)vs › | $9.62M | 2.06 | 1.94 | 2.63 | 3.51 |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | 1.11 | 14.91 | 8.99 | 8.14 |
Current Ratio
0.83
Quick Ratio
0.83
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.83 |
| 2026-03-31 | 1.04 |
| 2025-12-31 | 1.67 |
| 2025-09-30 | 1.51 |
| 2025-06-30 | 3.26 |
| 2025-03-31 | 4.22 |
| 2024-12-31 | 4.49 |
| 2024-09-30 | 1.92 |
| 2024-06-30 | 4.89 |
| 2024-03-31 | 5.79 |
| 2023-12-31 | 5.62 |
| 2023-09-30 | 7.81 |
| 2023-06-30 | 6.09 |
| 2023-03-31 | 6.26 |
| 2022-12-31 | 5.68 |
| 2022-09-30 | 7.56 |
| 2022-06-30 | 8.09 |
| 2022-03-31 | 0.20 |
| 2021-12-31 | 4.04 |
| 2021-09-30 | 12.86 |
| 2021-06-30 | 30.88 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 6.52 |
